Impact of timing of radiotherapy in patients with newly diagnosed glioblastoma (original ) (raw )RT-14 * Time to Radiation Therapy in Glioblastoma Multiforme: Is Sooner Better?
Heather Kistka
Neuro-oncology, 2014
View PDFchevron_right
Impact of Timing of Concurrent Chemoradiation for Newly Diagnosed Glioblastoma
Nicholas Butowski , Dario J Englot , Harjus Birk
Neurosurgery, 2015
View PDFchevron_right
Treatment and survival of patients harboring histological variants of glioblastoma
Chirag Patil
Journal of Clinical Neuroscience, 2014
View PDFchevron_right
Impact of radiotherapy delay on survival in glioblastoma
Teresa Ribalta , Estela Pineda
Clinical and Translational Oncology, 2013
View PDFchevron_right
Prognostic Factors of Local Control and Survival in Patients Irradiated for Glioblastoma Multiforme (GBM)
Steven Schild
Anticancer Research, 2020
View PDFchevron_right
Recent updates in the treatment of glioblastoma: introduction
Steven Brem
Seminars in oncology, 2014
View PDFchevron_right
Short Course versus Standard Course of Radiotherapy in Glioblastoma Multiforme
Amr Sakr
Journal of Nuclear Medicine & Radiation Therapy, 2018
View PDFchevron_right
Impact of waiting time after surgery and overall time of postoperative radiochemotherapy on treatment outcome in glioblastoma multiforme
Steffen Löck
Radiation Oncology, 2015
View PDFchevron_right
A population-based study of glioblastoma multiforme
Eric Holowaty
International Journal of Radiation Oncology*Biology*Physics, 2001
View PDFchevron_right
Patterns of care and outcome for patients with glioblastoma diagnosed during 2008-2010 in Spain
Inés Barceló
Neuro-Oncology, 2013
View PDFchevron_right
Early postoperative tumor progression predicts clinical outcome in glioblastoma-implication for clinical trials
Martin Proescholdt
Journal of neuro-oncology, 2017
View PDFchevron_right
Delayed initiation of radiotherapy for glioblastoma: how important is it to push to the front (or the back) of the line?
Felix Bokstein , Deborah Blumenthal
Journal of Neuro-Oncology, 2011
View PDFchevron_right
Current Standards of Care in Glioblastoma Therapy
Ligia Osorio
Codon Publications eBooks, 2017
View PDFchevron_right
A clinical review of treatment outcomes in glioblastoma multiforme--thevalidation in a non-trial population of the results of a randomised PhaseIII clinical trial: has a more radical approach improved survival?
Mary Dunne
British Journal of Radiology, 2012
View PDFchevron_right
Concurrent chemoradiotherapy versus radiotherapy alone for “biopsy-only” glioblastoma multiforme
SHIJIA WANG
Cancer, 2016
View PDFchevron_right
The butterfly effect on glioblastoma: is volumetric extent of resection more effective than biopsy for these tumors?
Ana Julia Cristina Nascimento Lemos
Journal of Neuro-Oncology, 2014
View PDFchevron_right
Long-term glioblastoma multiforme survivors: a population-based study
G. Sutherland
Canadian journal of …, 1998
View PDFchevron_right
Survival impact of time to initiation of chemoradiotherapy after resection of newly diagnosed glioblastoma
Michael Ivan
Journal of neurosurgery, 2015
View PDFchevron_right
Clinical characterization of glioblastoma patients living longer than 2 years: A retrospective analysis of two Italian institutions
Cynthia Aristei
Asia-Pacific Journal of Clinical Oncology, 2020
View PDFchevron_right
Scale to predict survival after surgery for recurrent glioblastoma multiforme
Donna Dello Iacono
Journal of Clinical …, 2010
View PDFchevron_right
Post progression survival in glioblastoma: where are we?
Girolamo Crisi
Journal of Neuro-Oncology, 2014
View PDFchevron_right
Timing of glioblastoma surgery and patient outcomes: a multicenter cohort study
Wim Bouwknegt
Neuro-Oncology Advances, 2021
View PDFchevron_right
P14.62 Overall survival from glioblastoma: partial resection versus biopsy
Rupavathana Mahesparan
Neuro-oncology, 2021
View PDFchevron_right
Overall survival, prognostic factors, and repeated surgery in a consecutive series of 516 patients with glioblastoma multiforme
Carl Langberg , Eirik Helseth
Acta Neurologica Scandinavica, 2010
View PDFchevron_right
Retrospective and Randomized Analysis of Influence and Correlation of Clinical and Molecular Prognostic Factors in a Mono-Operative Series of 122 Patients with Glioblastoma Treated with STR or GTR
Santi Galletta
Brain Sciences, 2020
View PDFchevron_right
Clinical prognostic factors in newly diagnosed glioblastoma
Oana Trifanescu
Romanian Journal of Neurology
View PDFchevron_right
Eighteen years’ experience with tumor treating fields in the treatment of newly diagnosed glioblastoma
Jan Sroubek
Frontiers in Oncology, 2023
View PDFchevron_right
P11.04 Autonomy duration as analyzed by KPS≥70 cumulative time in patients with biopsy-only glioblastoma (BO-GBM). A sub-analysis of the Timone cohort
Olivier Chinot
Neuro-Oncology, 2021
View PDFchevron_right
Survival of patients with glioblastoma multiforme has not improved between 1993 and 2004: analysis of 625 cases
alison loosemore
British Journal of Neurosurgery, 2007
View PDFchevron_right
Survival in a consecutive series of 467 glioblastoma patients: Association with prognostic factors and treatment at recurrence at two independent institutions
Mohummad Aminur Rahman
PLOS ONE, 2023
View PDFchevron_right
Optimal timing of chemoradiotherapy after surgical resection of glioblastoma: Stratification by validated prognostic classification
Soma Sengupta
Cancer, 2020
View PDFchevron_right
Delay in starting radiotherapy due to neoadjuvant therapy does not worsen survival in unresected glioblastoma patients
O. Gallego
Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2018
View PDFchevron_right
Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics
Michon Morita
Journal of neuro- …, 1996
View PDFchevron_right
Retrospective Analysis of Prognostic Factors in Adult Glioblastoma Multiforme: A Single Institution Experience
ahmed gaballah
Research in Oncology
View PDFchevron_right
Trends in glioblastoma: outcomes over time and type of intervention: a systematic evidence based analysis
Julie Hammack
Journal of Neuro-Oncology, 2020
View PDFchevron_right